Literature DB >> 11884533

Destiny of unspliced retroviral RNA: ribosome and/or virion?

Melinda Butsch1, Kathleen Boris-Lawrie.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11884533      PMCID： PMC136024          DOI： 10.1128/jvi.76.7.3089-3094.2002

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  42 in total

1.  Autogenous regulation of RNA translation and packaging by Rous sarcoma virus Pr76gag.

Authors:  T S Sonstegard; P B Hackett
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

Review 2.  RNA packaging.

Authors:  R Berkowitz; J Fisher; S P Goff
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

3.  cis Elements required for high-level expression of unspliced Gag-containing message in Moloney murine leukemia virus.

Authors:  M Oshima; T Odawara; K Hanaki; H Igarashi; H Yoshikura
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

4.  Characterization of an internal ribosomal entry segment within the 5' leader of avian reticuloendotheliosis virus type A RNA and development of novel MLV-REV-based retroviral vectors.

Authors:  M López-Lastra; C Gabus; J L Darlix
Journal:  Hum Gene Ther       Date:  1997-11-01       Impact factor: 5.695

5.  Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation.

Authors:  M S McBride; M D Schwartz; A T Panganiban
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2.

Authors:  E M McCann; A M Lever
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.

Authors:  B Wolff; J J Sanglier; Y Wang
Journal:  Chem Biol       Date:  1997-02

8.  Towards developing HIV-2 lentivirus-based retroviral vectors for gene therapy: dual gene expression in the context of HIV-2 LTR and Tat.

Authors:  M R Sadaie; M Zamani; S Whang; N Sistron; S K Arya
Journal:  J Med Virol       Date:  1998-02       Impact factor: 2.327

9.  Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors.

Authors:  E Poeschla; J Gilbert; X Li; S Huang; A Ho; F Wong-Staal
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging.

Authors:  S K Arya; M Zamani; P Kundra
Journal:  Hum Gene Ther       Date:  1998-06-10       Impact factor: 5.695
View more
  68 in total

1.  Viral regulation of mRNA export.

Authors:  Rozanne M Sandri-Goldin
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 2.  Function of a retrotransposon nucleocapsid protein.

Authors:  Suzanne B Sandmeyer; Kristina A Clemens
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  Dynamics of HIV-1 RNA Near the Plasma Membrane during Virus Assembly.

Authors:  Luca Sardo; Steven C Hatch; Jianbo Chen; Olga Nikolaitchik; Ryan C Burdick; De Chen; Christopher J Westlake; Stephen Lockett; Vinay K Pathak; Wei-Shau Hu
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

4.  Virus-like particles of the Ty3 retrotransposon assemble in association with P-body components.

Authors:  Nadejda Beliakova-Bethell; Carla Beckham; Thomas H Giddings; Mark Winey; Roy Parker; Suzanne Sandmeyer
Journal:  RNA       Date:  2006-01       Impact factor: 4.942

5.  The red clover necrotic mosaic virus RNA2 trans-activator is also a cis-acting RNA2 replication element.

Authors:  Masahiro Tatsuta; Hiroyuki Mizumoto; Masanori Kaido; Kazuyuki Mise; Tetsuro Okuno
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Ty3 nucleocapsid controls localization of particle assembly.

Authors:  Liza S Z Larsen; Nadejda Beliakova-Bethell; Virginia Bilanchone; Min Zhang; Anne Lamsa; Rhonda Dasilva; G Wesley Hatfield; Kunio Nagashima; Suzanne Sandmeyer
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 7.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

8.  In vitro expression of the HIV-2 genomic RNA is controlled by three distinct internal ribosome entry segments that are regulated by the HIV protease and the Gag polyprotein.

Authors:  Emiliano P Ricci; Cécile H Herbreteau; Didier Decimo; Andreas Schaupp; Siddhartha A K Datta; Alan Rein; Jean-Luc Darlix; Théophile Ohlmann
Journal:  RNA       Date:  2008-05-21       Impact factor: 4.942

Review 9.  How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.

Authors:  Jaisri R Lingappa; Jonathan C Reed; Motoko Tanaka; Kasana Chutiraka; Bridget A Robinson
Journal:  Virus Res       Date:  2014-07-24       Impact factor: 3.303

10.  RU5 of Mason-Pfizer monkey virus 5' long terminal repeat enhances cytoplasmic expression of human immunodeficiency virus type 1 gag-pol and nonviral reporter RNA.

Authors:  Stacey Hull; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.